ATE163412T1 - Pyridazine als interleukin-1-beta verwandlungsenzym inhibitoren - Google Patents
Pyridazine als interleukin-1-beta verwandlungsenzym inhibitorenInfo
- Publication number
- ATE163412T1 ATE163412T1 AT94201597T AT94201597T ATE163412T1 AT E163412 T1 ATE163412 T1 AT E163412T1 AT 94201597 T AT94201597 T AT 94201597T AT 94201597 T AT94201597 T AT 94201597T AT E163412 T1 ATE163412 T1 AT E163412T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- aryl
- chr5
- compounds
- interleukin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7391493A | 1993-06-08 | 1993-06-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE163412T1 true ATE163412T1 (de) | 1998-03-15 |
Family
ID=22116553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94201597T ATE163412T1 (de) | 1993-06-08 | 1994-06-04 | Pyridazine als interleukin-1-beta verwandlungsenzym inhibitoren |
Country Status (18)
Country | Link |
---|---|
US (3) | US6121266A (de) |
EP (1) | EP0628550B1 (de) |
JP (1) | JPH0769894A (de) |
KR (1) | KR950000673A (de) |
AT (1) | ATE163412T1 (de) |
AU (1) | AU693786B2 (de) |
CA (1) | CA2125359A1 (de) |
CZ (1) | CZ140194A3 (de) |
DE (1) | DE69408598T2 (de) |
DK (1) | DK0628550T3 (de) |
ES (1) | ES2114654T3 (de) |
FI (1) | FI942693A (de) |
HU (1) | HUT67413A (de) |
IL (1) | IL109918A0 (de) |
NO (1) | NO306061B1 (de) |
NZ (1) | NZ260698A (de) |
RU (1) | RU94019984A (de) |
SK (1) | SK69794A3 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6008217A (en) * | 1995-12-20 | 1999-12-28 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
US6204261B1 (en) | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
US5874424A (en) * | 1995-12-20 | 1999-02-23 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
DK0628550T3 (da) | 1993-06-08 | 1998-09-28 | Vertex Pharma | Pyridazin som interleukin-1 beta-omdannede enzyminhibitorer |
US6420522B1 (en) | 1995-06-05 | 2002-07-16 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
US5847135A (en) * | 1994-06-17 | 1998-12-08 | Vertex Pharmaceuticals, Incorporated | Inhibitors of interleukin-1β converting enzyme |
US5756466A (en) * | 1994-06-17 | 1998-05-26 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
US5716929A (en) * | 1994-06-17 | 1998-02-10 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
CA2215211A1 (en) * | 1995-03-31 | 1996-10-03 | Takeda Chemical Industries, Ltd. | Cysteine protease inhibitor |
US5843904A (en) * | 1995-12-20 | 1998-12-01 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1βconverting enzyme |
GB9715640D0 (en) * | 1997-07-24 | 1997-10-01 | M J Highway Technology Limited | Road repair material |
TWI241295B (en) * | 1998-03-02 | 2005-10-11 | Kowa Co | Pyridazine derivative and medicine containing the same as effect component |
JP2000247959A (ja) | 1999-02-26 | 2000-09-12 | Kowa Co | ピリダジン−3−オン誘導体及びこれを含有する医薬 |
EP2329842A3 (de) | 2000-05-12 | 2011-07-27 | Immunex Corporation | Interleukin-1 Inhibitoren zur Behandlung von Erkrankungen |
US6664256B1 (en) | 2000-07-10 | 2003-12-16 | Kowa Co., Ltd. | Phenylpyridazine compounds and medicines containing the same |
US20030176437A1 (en) | 2001-08-31 | 2003-09-18 | D.M. Watterson | Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
TWI314455B (en) * | 2002-12-10 | 2009-09-11 | Nippon Kayaku Kk | 3-phenyl-cinnoline derivatives and anti-tumor agent containing the same |
WO2004083188A1 (ja) | 2003-03-18 | 2004-09-30 | Kowa Co., Ltd. | 水溶性フェニルピリダジン誘導体及びこれを含有する医薬 |
TW200529845A (en) * | 2003-12-12 | 2005-09-16 | Wyeth Corp | Quinolines useful in treating cardiovascular disease |
EP2784090A1 (de) * | 2004-02-26 | 2014-10-01 | Baylor Research Institute | Zusammensetzungen zur Behandlung von systemischen Ausbruchs juveniler idiopathischer Arthritis |
US20060128696A1 (en) * | 2004-05-15 | 2006-06-15 | Annamaria Vezzani | Treating seizures using ice inhibitors |
GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
BRPI0517947A (pt) | 2004-11-02 | 2008-10-21 | Univ Northwestern | composto de piridazina, composições e métodos |
WO2006050359A2 (en) | 2004-11-02 | 2006-05-11 | Northwestern University | Pyridazine compounds and methods |
WO2007127474A2 (en) | 2006-04-28 | 2007-11-08 | Northwestern University | Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
WO2007127475A2 (en) * | 2006-04-28 | 2007-11-08 | Northwestern University | Pyridazines for demyelinating diseases and neuropathic pain |
CN101754762A (zh) | 2006-04-28 | 2010-06-23 | 西北大学 | 用于治疗神经炎症性疾病的包含哒嗪化合物的制剂 |
WO2012075393A2 (en) * | 2010-12-02 | 2012-06-07 | President And Fellows Of Harvard College | Activators of proteasomal degradation and uses thereof |
US9956260B1 (en) | 2011-07-22 | 2018-05-01 | The J. David Gladstone Institutes | Treatment of HIV-1 infection and AIDS |
KR102419136B1 (ko) | 2017-06-15 | 2022-07-08 | 삼성전자주식회사 | 다채널 특징맵을 이용하는 영상 처리 장치 및 방법 |
US20210139456A1 (en) * | 2018-07-09 | 2021-05-13 | Lieber Institute, Inc. | Pyridazine compounds for inhibiting nav1.8 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1603244A (en) * | 1977-05-20 | 1981-11-18 | Max Planck Gesellschaft | Medicaments for the suppression of pathological processes |
FR2511366A1 (fr) * | 1981-08-11 | 1983-02-18 | Sanofi Sa | Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent |
US4590194A (en) * | 1981-10-05 | 1986-05-20 | Sterling Drug Inc. | 3-[methyl or dimethyl)amino]-6-(pyridinyl)pyridazines and their cardiotonic use |
AU601145B2 (en) * | 1985-03-01 | 1990-09-06 | Duphar International Research B.V. | Benzoyl urea derivatives having anti-tumor activity |
US5055451A (en) * | 1986-12-22 | 1991-10-08 | Syntex Inc. | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors |
DE4134467A1 (de) * | 1991-10-18 | 1993-04-22 | Thomae Gmbh Dr K | Heterobiarylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
US5081145A (en) * | 1990-02-01 | 1992-01-14 | Merck Frosst Canada, Inc. | Indole-2-alkanoic acids compositions of and anti allergic use thereof |
WO1991015577A1 (en) * | 1990-04-04 | 1991-10-17 | Black, Roy, A. | INTERLEUKIN 1'beta' PROTEASE |
CA2071674C (en) * | 1991-06-21 | 2003-08-19 | Kevin T. Chapman | Peptidyl derivatives as inhibitors of interleukin-1.beta. converting enzyme |
DK0628550T3 (da) | 1993-06-08 | 1998-09-28 | Vertex Pharma | Pyridazin som interleukin-1 beta-omdannede enzyminhibitorer |
-
1994
- 1994-06-04 DK DK94201597T patent/DK0628550T3/da active
- 1994-06-04 ES ES94201597T patent/ES2114654T3/es not_active Expired - Lifetime
- 1994-06-04 AT AT94201597T patent/ATE163412T1/de not_active IP Right Cessation
- 1994-06-04 EP EP94201597A patent/EP0628550B1/de not_active Expired - Lifetime
- 1994-06-04 DE DE69408598T patent/DE69408598T2/de not_active Expired - Lifetime
- 1994-06-07 SK SK697-94A patent/SK69794A3/sk unknown
- 1994-06-07 AU AU64556/94A patent/AU693786B2/en not_active Ceased
- 1994-06-07 NZ NZ260698A patent/NZ260698A/en unknown
- 1994-06-07 KR KR1019940012681A patent/KR950000673A/ko not_active Application Discontinuation
- 1994-06-07 CA CA002125359A patent/CA2125359A1/en not_active Abandoned
- 1994-06-07 IL IL10991894A patent/IL109918A0/xx unknown
- 1994-06-07 RU RU94019984/04A patent/RU94019984A/ru unknown
- 1994-06-07 JP JP6125091A patent/JPH0769894A/ja active Pending
- 1994-06-08 FI FI942693A patent/FI942693A/fi unknown
- 1994-06-08 CZ CZ941401A patent/CZ140194A3/cs unknown
- 1994-06-08 NO NO942133A patent/NO306061B1/no not_active IP Right Cessation
- 1994-06-08 HU HU9401714A patent/HUT67413A/hu unknown
-
1995
- 1995-05-19 US US08/444,984 patent/US6121266A/en not_active Expired - Lifetime
-
1996
- 1996-04-03 US US08/625,680 patent/US6624166B1/en not_active Expired - Fee Related
-
2003
- 2003-09-22 US US10/668,475 patent/US6995261B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO942133D0 (no) | 1994-06-08 |
JPH0769894A (ja) | 1995-03-14 |
SK69794A3 (en) | 1995-02-08 |
EP0628550A3 (en) | 1995-01-18 |
AU693786B2 (en) | 1998-07-09 |
ES2114654T3 (es) | 1998-06-01 |
DE69408598D1 (de) | 1998-04-02 |
US6624166B1 (en) | 2003-09-23 |
HU9401714D0 (en) | 1994-09-28 |
EP0628550A2 (de) | 1994-12-14 |
NO942133L (no) | 1994-12-09 |
US6995261B2 (en) | 2006-02-07 |
NZ260698A (en) | 1996-09-25 |
FI942693A0 (fi) | 1994-06-08 |
RU94019984A (ru) | 1997-04-10 |
DE69408598T2 (de) | 1998-09-17 |
FI942693A (fi) | 1994-12-09 |
HUT67413A (en) | 1995-04-28 |
KR950000673A (ko) | 1995-01-03 |
CA2125359A1 (en) | 1994-12-09 |
AU6455694A (en) | 1994-12-15 |
DK0628550T3 (da) | 1998-09-28 |
EP0628550B1 (de) | 1998-02-25 |
US6121266A (en) | 2000-09-19 |
US20040110725A1 (en) | 2004-06-10 |
NO306061B1 (no) | 1999-09-13 |
IL109918A0 (en) | 1994-10-07 |
CZ140194A3 (en) | 1995-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE163412T1 (de) | Pyridazine als interleukin-1-beta verwandlungsenzym inhibitoren | |
NO174296C (no) | Analogifremgangsmåte til fremstilling av terapeutisk aktive 1-indolylalkyl-4-(substituert-pyridinyl)piperaziner | |
NO20015448L (no) | Kinolinderivater som inhibitorer av MEK-enzymer | |
DE69332860D1 (de) | Bicyklische fibrinogen antagoniste | |
MY100574A (en) | 5-substituted-2-cyclopropyl-6, 8-difluoroquinoline derivatives and processes for preparation thereof | |
ES2073398T3 (es) | Nuevos derivados substituidos del acido bencilideno- y cinamilideno-malonico con actividad como inhibidores de la proliferacion celular. | |
HUT52059A (en) | Process for producing pharmaceutical compositions and new quinoline derivatives as a group of active components | |
ES2064361T3 (es) | Nuevos compuestos. | |
FI834791A (fi) | Foerfarande foer framstaellning av pyrinderivat. | |
MY103505A (en) | Hetercoyclic oxophthalazinyl acetic acids | |
WO1986007059A3 (en) | Oxodiazine compounds | |
DE3572808D1 (en) | 4-(nitrophenyl)-tetrahydropyridines, process for their preparation and their application as pharmaceutical compounds | |
MY101815A (en) | Heterocyclic oxophthalazinyl acetic acids. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |